Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
February, 2026
February 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
232425262728  
Albert Farrugia: When Will FV Deficiency Get the Attention It Deserves?
Transfusion Journal/ transfusion.org
Aug 28, 2025, 18:54

Albert Farrugia: When Will FV Deficiency Get the Attention It Deserves?

Albert Farrugia, Clinical professor at The University of Western Australia, shared an insightful post on LinkedIn:

“The largest series, as far as I’m aware, on the use of FX concentrate in this extremely rare deficiency.
When are we going to see some effort for FV deficiency. I anticipate efficacy with many of the bypassing agents.
It’s disappointing not to see FV deficient patients included in the trials.

Read the full article:”

Article: Characterization and management of patients with hereditary factor X deficiency: A case series

Authors: Meera Chitlur, Lauren E. Amos, Mark T. Reding, Cynthia Sabo, Suchitra S. Acharya

Albert Farrugia: When Will FV Deficiency Get the Attention It Deserves?

Stay updated with Haemostasis Today.

Albert Farrugia Bypassing agents Cynthia Sabo FV deficiency FX concentrate Health Hematology Hemostasis Today Lauren E. Amos Mark T. Reding Medicine Meera Chitlur Suchitra S. Acharya The University of Western Australia Trials
NewsFeed